Aktas O, Hartung HP. Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases. Journal of Neurology 2009; 256: 1906-1908.

Albrecht P, Schmitz M, Otto M, Hemmer B, Zerr I, Hartung HP, Methner A. Free caspase activity in CSF of patients with dementia. Journal of Neurology 2009; 256: 1561-1562.

Arendt G, Nolting T. Cytokines in HIV-Infection - Inflammatory Damage or Therapeutic Potential? Anti-Inflammatory & Anti-Allergy Agents 2009; 8: 115-130.

Arendt, G (ed.) Neurologische Probleme bei HIV und AIDS. Forum Reihe der Deutschen AIDS-Hilfe, 2009.

Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW. The a-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultered Schwann cells. Neurobiology of Disease 2009; 33: 448-458.

Bauer A, Ishiwata K. Adenosine receptor ligands and PET imaging of the CNS. Handbook of Experimental Pharmacology 2009 193: 617-42.

Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, Zipp F, Paul F. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology2009; 73: 1624-1627.

Bellmann-Strobl J, Stiepani H, Wuerfel J, Bohner G, Paul F, Warmuth C, Aktas O, Wandinger KP, Zipp F, Klingebiel R. MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study. European Radiology 2009; 19: 2066-2074.

Bernal F, Elias B, Hartung HP, Kieseier BC. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients. Multiple Sclerosis 2009; 15: 721-727.

Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE. Nucleus accumbens deep brain stimulation decreasesratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry 2009; 67:110-6.

Blondin D, Seitz RJ, Rusch O, Janssen H, Andersen K, Wittsack HJ, Turowski B. Clinical impact of MRI perfusion disturbances and normal diffusion in acute stroke patients. European Journal of Radiology 2009; 71: 1-10.

Bode FJ, Stephan M, Wiehager S, Nguyen HP, Björkqvist M, von Hörsten S, Bauer A, Petersén A. Increased numbers of motor activity peaks during light cycle are ssociated with reductions in adrenergic alpha(2)-receptor levels in a transgenic untington's disease rat model. Behavioural Brain Research 2009; 205:175-82.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG; PERFORM Study Investigators [Jander S]. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovascular Diseases 2009; 27: 509-518.

Brazda N, Müller HW. Pharmacological modification of the extracellular matrix to promote regeneration of the injured brain and spinal cord. In: Verhaagen J, Hol EM, Huitinga I, Wijnholds J, Bergen AB, Boer GJ, Swaab DF (eds.) Progress in Brain Research. Elsevier, Oxford, 2009; 175: 269-281.

Bril V, Katzberg H, Donofrio P, Banach M, Dalakas MC, Deng C, Hanna K, Hartung HP, on behalf of the ICE Study Group. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV. Muscle & Nerve 2009; 39: 448-455.

Buhren BA, Gasis M, Thorens B, Müller HW, Bosse F. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth. Journal of Neuroscience Research 2009; 87: 1858-1870.

Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer H. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis. Archives of Neurology 2009; 66: 1216-1223.

Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung HP, Hillert J, King J, Komoly S, Lubetzki C, Montalban X, Myhr KM, Ravnborg M, Rieckmann P, Wynn D, Young C, Filippi M; for the PreCISe study group. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet2009; 374: 1503-1511.

De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Hartung HP, et al.; Steering committees of the BENEFIT, BEYOND, LTF, and CCR1 studies. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score Lancet Neurology 2009; 8: 1111-1119.

del Pilar Martin M, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-DeMasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. Depletion of B lymphocytes from cerebral perivascular spaces by Rituximab. Archives of Neurology 2009; 66: 1016-1020.

Diener HC, Hartung HP, Bien CG, Hacke W, Ringelstein EB, Ludolph A, Deusch G, Wiltfang J, Weller M, Steinhausen K, Stemper B, Klatt J, Drepper J, Griewing B, Meier U, Herschel M, Hummel K, Paar WD, Dintsios CM, Schade-Brittinger C, Weber R, Weimar C. Klinische Studien in der Neurologie in Deutschland 2008. Aktuelle Neurologie 2009; 36: 1-11.

Elmenhorst D, Basheer R, McCarley RW, Bauer A. Sleep deprivation increases A1 adenosine receptor density in the rat brain. Brain Research 2009; 1258: 53-58.

Fazekas F, Kieseier BC. Translating new insights into treatment optimisation in multiple sclerosis. Journal of the Neurological Sciences 2009; 277: Suppl. 1: 1-2.

Görtz P, Opatz J, Siebler M, Funke SA, Willbold D, Lange-Asschenfeldt C. Transient reduction of spontaneous neuronal network activity by sublethal amyloid beta (1-42) peptide concentrations. Journal of Neural Transmission 2009; 116: 351-355.

Gold R, Hartung HP, Hohlfeld R, Wiendl H, Kieseier BC, Linker RA, Schmidt S, Toyka KV, für die Arbeitsgruppe Moderne Immuntherapie der MS. Therapie der Multiplen Sklerose mit monoklonalen Antikörpern. Aktuelle Neurologie 2009; 36: 334-344.

Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ; Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators [Jander S]. The Expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. American Heart Journal 2009; 158: 193-201.

Gorelik L, Goelz S, Sandrock AW, De Gascun CF, Lonergan RM, Hall WW, Warnke C, Adams O, Kieseier BC, Tan CS, Kinkel RP, Koralnik IJ. Asymptomatic reactivation of JC virus in patients treated with Natalizumab. New England Journal of Medicine 2009; 361: 2487-2490.

Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A. Deep brain stimulation in Parkinson's disease. Therapeutic Advances in Neurological Disorders 2009; 2: 379-391.

Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P; members of the ISHEN commission on Neurophysiological Investigations. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver International2009; 29: 789-796.

Hacke W, Diener HC, Hartung HP, Elger C, Brandt TH. Messung von Publikationsleistungen. Nervenarzt 2009; 80: 1226-1238.

Hartung HP. High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis. Expert Opinion on Pharmacotherapy 2009; 10: 291-309.

Hartung HP. New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Lancet Neurology 2009; 8: 28-31.

Hartung HP, Warnke C, Hohlfeld R, Kieseier BC. Progressive multifokale Leukenzephalopathie. Nervenarzt 2009; 80: 1143-1153.

Hartung HP. Atacicept: ein neuer B-Lymphozyten gerichteter Therapieansatz bei Multipler Sklerose. Nervenarzt 2009; 80: 1462-1472.

Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland KB, Jolles S. Clinical applications of intravenous immunoglobulins (IVIg) - Beyond immunodeficiencies and neurology. Clinical and Experimental Immunology 2009; 158: 23-33.

Hartung HP, Aktas O. Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope. Annals of Neurology 2009; 66: 429-432.

Hartung HP. New oral therapies may offer improved treatment options for patients with multiple sclerosis. Current Opinion in Neurology (Suppl.) 2009; 22: S10-S14.

Höllerhage M, Matusch A, Champy P, Lombès A, Ruberg M, Oertel WH, Höglinger GU. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies. Experimental Neurology 2009; 220: 133-42.

Hofstetter HH, Stüve O, Hartung HP. Is 1+1 0, 1, 2, or 11? Arithmetics of antiinflammatory agents in autoimmunity. Experimental Neurology 2009; 217: 4-6.

Hofstetter H, Gold R, Hartung HP. Th17 cells in MS and Experimental Autoimmune Encephalomyelitis. International MS Journal 2009; 16: 12-18.

Hofstetter HH, Smolianov V, Hartung HP. Untired regulatory T cells: untying fatigue from T cell regulation in multiple sclerosis. European Journal of Neurology 2009; 62: 327-329.

Hu W, Metselaar J, Cravens PD, Singh MP, Frohman E, Eager TN, Racke MK, Kieseier BC, Stüve O. PEG minocycline-liposomes ameliorate CNS autoimmune disease. PLoS ONE2009; 4: e4151.

Hurlemann R, Schlaepfer TE, Matusch A, Reich H, Shah NJ, Zilles K, Maier W, Bauer A. Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage. Social Cognitive and Affective Neuroscience 2009; 4: 79-84.

Husstedt IW, Reichelt D, Neuen-Jakob E, Hahn K, Kästner F, von Einsiedel R, Vielhaber B, Arendt G, Evers S. Hochaktive antiretrovirale Therapie bei Neuro-AIDS. Nervenarzt 2009; 80: 1133-1142.

Husstedt IW, Reichelt D, Neuen-Jacob E, Kästner F, von Einsiedel R, Vielhaber B, Arendt G, Evers S, Hahn K. Neurotoxicity and Side-Effects of Highly Active Antiretroviral Therapy [HAART] on the Central and Peripheral Nervous System. Anti-Inflammatory & Anti-Allergy Agents 2009; 8: 192-201.

Illes S, Theiss S, Hartung HP, Siebler M, Dihné M. Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populations. BMC Neuroscience 2009; 10: 93.

Jangouk P, Dehmel T, Meyer zu Hörste G, Ludwig A, Lehmann HC, Kieseier BC. Involvement of ADAM10 in axonal outgrowth and myelination of the peripheral nerve. Glia 2009; 57: 1765-1774.

Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Metzig C, Bauer L, Lanius V, Sandbrink R, Pohl C; for the BENEFIT Study Group. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurology 2009; 8: 987-997.

Karenfort M, Kieseier BC, Tibussek D, Assmann B, Scharper J, Mayatepek E. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis. Developmental Medicine & Child Neurology 2009: 51: 159-161.

Kieseier BC, Wiendl H, Hartung HP, Stüve O. The future of multiple sclerosis therapy. Pharmacological Research 2009; 60: 207-211.

Kieseier BC. Neuroimmunologie - Immunpathogenetische Grundlagen der Multiplen Sklerose. Nervenheilkunde 2009; 28: 468-475.

Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, Häussinger D. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009; 137: 1706-1715.

Kircheis G, Bode JG, Kramer T, Schnitzler A, Häussinger D. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. European Journal of Gastroenterology & Hepatology 2009; 21: 1383-1394.

Kleiser R, Konen CS, Seitz RJ, Bremmer F. I know where you'll look: an fMRI study of oculomotor intention and a change of motor plan. Behavioral and Brain Functions 2009; 5: 27.

Kopadze T, Döbert M, Leussink VI, Dehmel T, Kieseier BC. Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis. European Journal of Neurology 2009; 16: 409-412.

Kremer D, Heinen A, Jadasz J, Göttle P, Zimmermann K, Zickler P, Jander S, Hartung HP, Küry P. p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 9087-9092.

Kremer H, Sonnenberg-Schwan U, Arendt G, Brockmeyer NH, Potthoff A, Ulmer A, Graefe K, Lorenzen T, Starke W, Walker UA; German Competence Network HIV/AIDS. HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. European Journal of Medical Research 2009; 14: 139-146.

Lehmann HC, Köhne A, Bernal F, Jangouk P, Meyer zu Hörste G, Dehmel T, Hartung HP, Previtali S, Kieseier BC. Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neurons. Glia 2009; 57; 479-489.

Lehmann HC, Hartung HP. Variants of Guillain-Barré syndrome: low incidence but high impact. Journal of Neurology 2009; 256: 1909-1910.

Lehmann HC, Kieseier BC. Predicting treatment responses to IV immunoglobulins. can we already ask the genes? Neurology 2009; 73: 1344-1345.

Lehmann HC, Meyer zu Hörste G, Kieseier BC, Hartung HP. Pathogenesis and treatment of immune-mediated neuropathies. Therapeutic Advances in Neurological Disorders2009; 2: 261-281.

Lewerenz J, Albrecht P, Tien ML, Henke N, Karumbayaram S, Kornblum HI, Wiedau-Pazos M, Schubert D, Maher P, Methner A. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. Journal of Neurochemistry 2009; 111: 332-343.

Lou HC, Gross J, Biermann-Ruben K, Kjaer TW, Schnitzler A. Coherence in consciousness: paralimbic gamma synchrony of self-reference links conscious experiences. Human Brain Mapping 2009; 31: 185-192.

Markus HS, Siegel JE, Topakian R, Schaafsma A, Reihill S; ACES Investigators [Siebler M]. The asymptomatic carotid emboli study; study design and baseline results. International Journal of Stroke 2009; 4: 398-405.

Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Archives of Neurology 2009; 66: 1016-1020.

Mausberg AK, Jander S, Reichmann G. Intracerebral granulocyte-macrophage colony-stimulating factor induces fuctionally competent dendritic cells in the mouse brain. Glia 2009; 57: 1341-1350.

Mehrkens JH, Bötzel K, Steude U, Zeitler K, Schnitzler A, Sturm V, Voges J. Long-term efficacy and safety of chronic globus pallidus internus stimulation in different types of primary dystonia. Stereotactic and Functional Neurosurgery 2009; 87: 8-17.

Menge T, von Büdingen HC, Kieseier BC, Hartung HP. B-Zell-gerichtete Multiple-Sklerose-Therapie. Nervenarzt 2009; 80: 190-198.

Menge T, Schloot NC, Schott M, Hemmer B, Wiendl H, Roden M, Hartung HP, Kieseier BC. Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis. Neurology 2009; 73: 900-902.

Menge T, Meyer zu Hörste G, Kieseier BC. The role of B cells in multiple sclerosis. Multiple Sclerosis 2009; 1: 1-7.

Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA, on behalf of the ICE Study Group. Health-related quality-of-life improvements in CIPD with immune globulin IV 10%. The ICE Study. Neurology 2009; 72: 1337-1344.

Meuth SG, Hermann AM, Simon OJ, Siffrin V, Melzer N, Bittner S, Meuth P, Langer HF, Hallermann S, Boldakowa N, Herz J, Munsch T, Landgraf P, Aktas O, Heckmann M, Lessmann V, Budde T, Kieseier BC, Zipp F, Wiendl H. Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death. Journal of Neuroscience 2009; 29: 15397-15409.

Meyer zu Hörste G, Reiners J, Lehmann HC, Airas L, Kieseier BC. CD73 is expressed on invading t lymphocytes in the inflamed peripheral nerve. Muscle & Nerve 2009; 40: 287-289.

Michels L, Kleiser R, de Lussanet MH, Seitz RJ, Lappe M. Brain activity for peripheral biological motion in the posterior superior temporal gyrus and the fusiform gyrus: Dependence on visual hemifield and view orientation. Neuroimage 2009; 45: 151-159.

Mobascher A, Brinkmeyer J, Warbrick T, Musso F, Wittsack HJ, Stoermer R, Saleh A, Schnitzler A, Winterer G. Fluctuations in electrodermal activity reveal variations in single trial brain responses to painful laser stimuli - A fMRI/EEG study. Neuroimage 2009; 44: 1081-1092.

Mobascher A, Brinkmeyer J, Warbrick T, Musso F, Wittsack HJ, Saleh A, Schnitzler A, Winterer G. Laser-evoked potential P2 single-trial amplitudes covary with the fMRI BOLD response in the medial pain system and interconnected subcortical structures. Neuroimage2009; 45: 917-926.

Moraal B, Pohl C, Uitdehaag BM, Polman CH, Edan G, Freedman MS, Hartung HP, Kappos L, Miller DH, Montalban X, Lanius V, Sandbrink R, Barkhof F. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Archives of Neurology2009; 66: 1345-1352.

Moraal B, Meier DS, Poppe PA, Geurts JJ, Vrenken H, Jonker WM, Knol DL, van Schijndel RA, Pouwels PJ, Pohl C, Bauer L, Sandbrink R, Guttmann CR, Barkhof F. Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. Radiology 2009; 250: 506-514.

Müller K, Kleiser R, Mechsner F, Seitz RJ. Perceptual influence on bimanual corrdination: an fMRI study. European Journal of Neuroscience 2009; 30: 116-124.

Nolting T, Arendt G. Pharmacogenomics - Implications in the Development of HIV-Associated Brain Disease. Anti-Inflammatory & Anti-Allergy Agents 2009; 8: 164-168.

Nolting T, Lindecke A, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stüve O, Hartung HP, Arendt G; Competence Network HIV/AIDS. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. Journal of Neurovirology 2009; 15: 390-400.

O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung HP, Jeffery D, Kappos L, Boateng F, Filippov V; for the BEYOND Study Group. 250 mg or 500 mg interferon beta-1b versus 20 mg glatiramer acetate in replasping-remitting multiple sclerosis: a prospective, randomised multicentre study. Lancet Neurology 2009; 8: 889-897.

Obermann M, Küper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, Koutsilieri E, Arendt G, Diener HC, Maschke M; German Competence Network HIV/AIDS. Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. Journal of Neurology 2009; 256: 948-953.

Opatz J, Küry P, Schiwy N, Järve A, Estrada V, Brazda N. Bosse F, Müller HW. SDF-1 stimulates neurite growth on inhibitory CNS myelin. Molecular and Cellular Neurosciences2009; 40: 293-300.

Otto F, Neuen-Jacob E, Arendt G, Stüve O, Hartung HP. A 69-year-old man with left hemispheric necrotizing mass lesion. Brain Pathology 2009; 19: 541-544.

Otto F, Illes S, Opatz J, Laryea M, Theiss S, Hartung HP, Schnitzler A, Siebler M, Dihné M. Cerebrospinal fluid of brain trauma patients inhibits neuronal network function via NMDA receptors. Annals of Neurology 2009; 66: 546-555.

Ploner M, Schoffelen JM, Schnitzler A, Gross J. Functional integration within the human pain system as revealed by Granger causality. Human Brain Mapping 2009; 30: 4025-4032.

Pollok B, Makhloufi H, Butz M, Gross J., Timmermann L, Wojtecki L, Schnitzler A. Levodopa affects functional brain networks in parkinsonian resting tremor. Movement Disorders 2009; 24: 91-98.

Pollok B, Krause V, Butz M, Schnitzler A. Modality specific functional interaction in sensorimotor synchronization. Human Brain Mapping 2009; 30: 1783-1790.

Pul R, Kopadze T, Skripuletz T, Voss EV, Kieseier BC, Stangel M. Polyclonal immunoglobulins (IVIg) induce expression of MMP-9 in microglia. Journal of Neuroimmunology 2009; 217: 46-50.

Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, Hoffmann F, Käfferlein W, Kausch U, Liedtke M, Kirchmeier J, Gmünd S, Richter A, Schicklmaier R, Niemczyk G, Wernsdörfer C, Hartung HP; for the "Mensch im Mittelpunkt" Study Group. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. European Journal of Neurology 2009; 16: 713-720.

Putzki N, Hartung HP (eds.) (2009) Treatment of Multiple Sclerosis.UNI-MED Verlag, Bremen.

Reck C, Florin E, Wojtecki L, Krause H, Groiss S, Voges J, Maarouf M, Sturm V, Schnitzler A, Timmermann L. Characterisation of tremor-associated local field potentials in the subthalamic nucleus in Parkinson's disease. European Journal of Neuroscience 2009; 29: 599-612.

Reck C, Florin E, Wojtecki L, Groiss S, Voges J, Sturm V, Schnitzler A, Timmermann L. Differential distribution of coherence between beta-band subthalamic oscillations and forearm muscles in Parkinson's disease during isometric contraction. Clinical Neurophysiology2009; 120: 1601-1609.

Ringelstein A, Oelschlaeger C, Saleh A, Mathys C, Dziewas R, Niederstadt T, Reichelt D, Hasselblatt M, Husstedt IW, Arendt G. Severe aseptic leucoencephalopathy as immune reconstitution inflammatory syndrome in Caucasian and African patients. AIDS 2009; 23: 1435-1437.

Schiwy N, Brazda N, Müller HW. Enhanced regenerative axon growth of multiple fibre populations in traumatic spinal cord injury following scar-suppressing treatment. European Journal of Neuroscience 2009; 30: 1544-1553.

Schnitzler A, Münks C, Butz M, Timmermann L, Gross J. Synchronized brain network associated with essential tremor as revealed by magnetoencephalography. Movement Disorders 2009; 24: 1629-1635.

Schulze Topphoff, U, Prat A, Prozorovski T, Siffrin V, Paterka M, Herz J, Bendix I, Ifergan I, Schadock I, Mori MA, van Horssen J, Schröter F, Smorodchenko A, Han MH, Bader M, Steinman L, Aktas O, Zipp F. Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nature Medicine 2009; 15: 788-793.

Seitz RJ, Franz M, Azari NP. Value judgments and self-control of action: the role of the medial frontal cortex. Brain Research Reviews 2009; 60: 368-378.

Seitz RJ, Sondermann V, Wittsack HJ, Siebler M. Lesion patterns in successful and failed thrombolysis in middle cerebral artery stroke. Neuroradiology 2009; 51: 865-871.

Seitz RJ. Brain representations of writing. GFL 2009; 2-3: 65-82.

Singh MP, zu Hörste GM, Hu W, Mausberg AK, Cravens PD, Eager T, Löber S, Klingenstein R, Gmeiner P, Korth C, Kieseier BC, Stüve O. Quinpramine is a novel compound effective in ameliorating brain autoimmune disease. Experimental Neurology 2009; 215: 397-400.

Sinis N, Di Scipio F, Schönle P, Werdin F, Kraus A, Koopmans G, Masanneck C, Hermanns S, Angelov DN, Danker T, Guenther E, Haerle M, Schaller HE, Geuna S, Müller HW. Local administration of DFO-loaded lipid particles improves recovery after end-to-end reconstruction of rat median nerve. Journal of Restorative Neurology & Neuroscience2009; 27: 651-662.

Skibinska-Kijek A, Wisniewska MB, Gruszczynska-Biegala J, Methner A, Kuznicki J. Immunolocalization of STIM1 in the mouse brain. Acta Neurobiologiae Experimentalis2009; 69: 413-428.

Stamelou M, Matusch A, Elmenhorst D, Hurlemann R, Eggert KM, Zilles K, Oertel WH, Höglinger GU, Bauer A. Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy. Movement Disorders 2009; 24: 1170-1175.

Stangel M, Hartung HP, Gold R. Kieseier BC. Bedeutung intravenöser Immunglobuline zur Behandlung immunvermittelter Polyneuropathien. Nervenarzt 2009; 80: 678-687.

Stoeckel MC, Seitz RJ, Bütefisch CM. Congentially altered motor experience alters somatotopic organization of human primary motor cortex. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 2395-2400.

Stüve O, Leussink VI, Fröhlich R, Hemmer B, Hartung HP, Menge T, Kieseier BC. Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis. Archives of Neurology 2009; 66: 259-261.

Stüve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G, Cepok S, et al. Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology 2009; 72: 396-401.

Thaut MH, Stephan KM, Wunderlich G, Schicks W, Tellmann L, Herzog H, McIntosh GC, Seitz RJ, Hömberg V. Distinct cortico-cerebellar activations in rhythmic auditory motor synchronization. Cortex 2009; 45: 44-53.

Thomalla G, Siebner HR, Jonas M, Bäumer T, Biermann-Ruben K, Hummel F, Gerloff C, Müller-Vahl K, Schnitzler A, Orth M, Münchau A. Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain 2009; 132: 765-777.

Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK, and the BioMS Study Group. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiology of Disease 2009; 35: 117-127.

Tysiak E, Asbach P, Aktas O, Waiczies H, Smyth M, Schnorr J, Taupitz M, Wuerfel J. Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI. Journal of Neuroinflammation 2009; 6: 20.

van Nes SI, Vanhoutte EK, Faber CG, Garssen M, van Doorn PA, Merkies IS, Hartung HP, et al.; PeriNomS Study Group. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale. Journal of the Peripheral Nervous System 2009; 14: 268-278.

Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Annals of Neurology 2009; 66: 310-322.

Volkmann J, Albanese A, Kulisevsky J, Tornqvist AL, Houeto JL, Pidoux B, Bonnet AM, Mendes A, Benabid AL, Fraix V, van Blercom N, Xie J, Obeso J, Rodriguez-Oroz MC, Guridi J, Schnitzler A, Timmermann L, Gironell AA, Molet J, Pascual-Sedano B, Rehncrona S, Moro E, Lang AC, Lozano AM, Bentivoglio AR, Scerrati M, Contarino MF, Romito L, Janssens M, Agid Y. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Movement Disorders 2009; 24: 1154-1161.

Vollmar P, Nessler S, Kalluri SR, Hartung HP, Hemmer B. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. International Journal of Neuropsychopharmacology 2009; 12: 525-536.

Vordenbäumen S, Groiss SJ, Dihné M. Isolated unilateral temporal muscle hypertrophy: a rare cause of hemicranial headache. Headache 2009; 49: 779-782.

Warnke C, Lanzman RS, Klink B, Schellhammer F, Reifenberger G, Methner A. Diffuse leptomeningeal astrocytoma in a patient with infantile epilepsy. Archives of Neurology 2009; 66: 408-409.

Warnke C, Meyer zu Hörste G, Hartung HP, Stüve O, Kieseier BC. Review of teriflunomide and its potential in the treatment of multiple sclerosis. Neuropsychiatric Disease and Treatment 2009; 5: 333-340.

Warnke C, Kieseier BC, Zettl U, Hartung HP. Alemtuzumab als neue Therapieoption der Multiplen Sklerose. Nervenarzt 2009; 80: 468-474.

Warnke C, Adams O, Kieseier BC. Asymptomatic reactivation of JC virus in patients treated with natalizumab. New England Journal of Medicine 2009; 361: 2489.

Wellen J, Walter J, Jangouk P, Hartung HP, Dihné M. Neural precursor cells as a novel target for interferon-beta. Neuropharmacology 2009; 56: 386-398.

Werdin F, Di Scipio F, Schönle P, Kraus A, Jaminet P, Koopmanns G, Danker T, Guenther G, Haerle M, Schaller HE, Geuna S, Mueller HW, Sinis N. Lokale Applikation von Deferroaxmin zur Verbesserung der Regeneration peripherer Nerven im Tierversuch. Obere Extremität2009; 4: 217-232.

Wojtecki L, Groiss S, Scherfeld D, Albrecht P, Pollok B, Elben S, Wille C, Vesper J, Schnitzler A. Transient improvement of psychogenic (proprio-)spinal-like myoclonus to electrical nerve stimulation. Movement Disorders 2009; 24: 2024-2025.

Wojtecki L, Südmeyer M, Schnitzler A. Therapie des idiopthischen Parkinson-Syndroms. CME Ärzteblatt Kompakt 2009; 24a.

Zickler P, Hartung HP, Janssen H. "Bubbles in the brain": retrograde venous air embolism in the cavernous sinus. European Neurology 2009; 61: 318.

MediathekInformation und Wissen
LageplanSo finden Sie uns